Alexion Pharmaceuticals (ALXN-Q) Stock Predictions - Stockchase
WATCH LIST
4
Alexion Pharmaceuticals (ALXN-Q)

ON STOCKCHASE SINCE Mar 2007

biotechnology/pharmaceutical

Alexion Pharmaceuticals

ALXN-Q

0 watching          
Join the Discussion

Alexion Pharmaceuticals (ALXN-Q) SAVE Apr, 23, 2019, 5:29 pm

132.37 3.41 (2.64%)

About Alexion Pharmaceuticals (ALXN-Q)

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. More at Wikipedia

What the experts are saying about ALXN-Q



  • All
  • Filtered
Signal Opinion Expert
COMMENT

Biotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Biotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Burrows

President , Barometer Capital Ma...

Price Price
$104.640
Owned Owned
Unknown

PAST TOP PICK

(Top Short Mar 9/07. Up 202%.) News on this was positive so he exited his short position.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Top Short Mar 9/07. Up 202%.) News on this was positive so he exited his short position.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$58.950
Owned Owned
No

PAST TOP PICK

(Top Short March 9/07.) You would have entered at about $37 and with your trailing stop you would have been out in a few days and probably would've broken even including your commissions. Had expected bad news, but they had some positive news.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Top Short March 9/07.) You would have entered at about $37 and with your trailing stop you would have been out in a few days and probably would've broken even including your commissions. Had expected bad news, but they had some positive news.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$47.290
Owned Owned
No

TOP PICK
Top Short There's a small problem with this stock. Around March 20 they are going to be releasing some news that might have major influence on the stock. Had a very long base around $34 and thinks this is where the stock is heading. Volumes are not large. Use a $1 trailing stop.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Top Short There's a small problem with this stock. Around March 20 they are going to be releasing some news that might have major influence on the stock. Had a very long base around $34 and thinks this is where the stock is heading. Volumes are not large. Use a $1 trailing stop.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$37.080
Owned Owned
No

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company